Translocation of Sphingosine Kinase 1 to the Plasma Membrane Is Mediated by Calcium- and Integrin-binding Protein 1

gan Jarman, Kate E., Moretti, Paul A. B., Zebol, Julia R., Pitson, Stuart M.
Cyhoeddwyd 2010

A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells

gan Beetham, Henry, Chen, Augustine, Telford, Bryony J., Single, Andrew, Jarman, Kate E., Lackovic, Kurt, Luxenburger, Andreas, Guilford, Parry
Cyhoeddwyd yn Sci Rep (2019)

Structural basis of substrate recognition and catalysis by fucosyltransferase 8

gan Järvå, Michael A., Dramicanin, Marija, Lingford, James P., Mao, Runyu, John, Alan, Jarman, Kate E., Grinter, Rhys, Goddard-Borger, Ethan D.
Cyhoeddwyd yn J Biol Chem (2020)

Development and application of a high-throughput screening assay for identification of small molecule inhibitors of the P. falciparum reticulocyte binding-like homologue 5 protein

gan Sleebs, Brad E., Jarman, Kate E., Frolich, Sonja, Wong, Wilson, Healer, Julie, Dai, Weiwen, Lucet, Isabelle S., Wilson, Danny W., Cowman, Alan F.
Cyhoeddwyd yn Int J Parasitol Drugs Drug Resist (2020)

CIB1 contributes to oncogenic signalling by Ras via modulating the subcellular localisation of sphingosine kinase 1

gan Zhu, Wenying, Gliddon, Briony L., Jarman, Kate E., Moretti, Paul A. B., Tin, Teresa, Parise, Leslie V., Woodcock, Joanna M., Powell, Jason A., Ruszkiewicz, Andrew, Pitman, Melissa R., Pitson, Stuart M.
Cyhoeddwyd yn Oncogene (2016)

Selective targeting of Cyclin E1 amplified high grade serous ovarian cancer by cyclin-dependent kinase 2 and AKT inhibition

gan Au-Yeung, George, Lang, Franziska, Azar, Walid J., Mitchell, Chris, Jarman, Kate E., Lackovic, Kurt, Aziz, Diar, Cullinane, Carleen, Pearson, Richard B, Mileshkin, Linda, Rischin, Danny, Karst, Alison M., Drapkin, Ronny, Etemadmoghadam, Dariush, Bowtell, David DL
Cyhoeddwyd yn Clin Cancer Res (2016)

Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors

gan Sharp, Phillip P., Garnier, Jean-Marc, Hatfaludi, Tamas, Xu, Zhen, Segal, David, Jarman, Kate E., Jousset, Hélène, Garnham, Alexandra, Feutrill, John T., Cuzzupe, Anthony, Hall, Peter, Taylor, Scott, Walkley, Carl R., Tyler, Dean, Dawson, Mark A., Czabotar, Peter, Wilks, Andrew F., Glaser, Stefan, Huang, David C. S., Burns, Christopher J.
Cyhoeddwyd yn ACS Med Chem Lett (2017)

Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models

gan Morrish, Emma, Copeland, Anthony, Moujalled, Donia M., Powell, Jason A., Silke, Natasha, Lin, Ann, Jarman, Kate E., Sandow, Jarrod J., Ebert, Gregor, Mackiewicz, Liana, Beach, Jessica A., Christie, Elizabeth L., Lewis, Alexander C., Pomilio, Giovanna, Fischer, Karla C., MacPherson, Laura, Bowtell, David D. L., Webb, Andrew I., Pellegrini, Marc, Dawson, Mark A., Pitson, Stuart M., Wei, Andrew H., Silke, John, Brumatti, Gabriela
Cyhoeddwyd yn Blood Adv (2020)